Genetic feature diversity of KRAS-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosis

Genetic feature diversity of KRAS-mutated colorectal cancer and the negative association of DNA mismatch repair deficiency relevant mutational signatures with prognosis

Saved in:

Bibliographic Details
Main Authors:	Ruichuan Shi, Yu Cheng, Jin Wang, Na Song, Ying Chen, Zan Teng, Ling Xu, Yunpeng Liu, Xiaotian Zhao, Qiuxiang Ou, Peng Yang, Rui Ma, Yiting Sun, Jinglei Qu, Xiujuan Qu
Format:	Article
Language:	English
Published:	KeAi Communications Co., Ltd. 2025-01-01
Series:	Genes and Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352304224000424
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The prognosis and adjuvant chemotherapy in KRAS mutation patients with stage I lung adenocarcinoma
by: Shangshang Ma, et al.
Published: (2024-12-01)

Clinicopathological Characteristics of Colorectal Cancer Patients with Different Mismatch Repair Statuses and Their Correlation with KRAS/NRAS/BRAF Gene Mutations
by: Jinchuan YU, et al.
Published: (2024-11-01)

Role of silent mutations in KRAS-mutant tumors
by: Jun Lu, et al.
Published: (2025-02-01)

KRAS mutations in patients with AML: clinical characteristics and not reported mutations using NGS
by: Salma Said Ibrahim Elsayed, et al.
Published: (2024-12-01)

The opposite association of HRAS and KRAS mutations with clinical variables of bladder cancer
by: M. P. Smal, et al.
Published: (2015-12-01)

Viral mimicry evasion: a new role for oncogenic KRAS mutations
by: Raymond Chen, et al.
Published: (2025-02-01)

Lynch Syndrome—Impact of the Type of Deficient Mismatch Repair Gene Mutation on Diagnosis, Clinical Presentation, Surveillance and Therapeutic Approaches
by: Tudor Razvan Grigorie, et al.
Published: (2025-01-01)

Tumor Mutation Signature Reveals the Risk Factors of Lung Adenocarcinoma with or Mutation
by: Jialiang Wang MM, et al.
Published: (2025-01-01)

Case report: Aggressive NSCLC with partial BRG-1 deficiency and KRAS G12C mutation: a case study and treatment challenges
by: Chengwei Jin, et al.
Published: (2024-12-01)

Effect of KRAS mutation status on clinicopathological characteristics and overall survival in patients with rectal cancer
by: Shengbin Zheng, et al.
Published: (2025-01-01)

KRAS Mutation in Serous Borderline Tumor of the Testis: Report of a Case and Review of the Literature
by: Sarah Bouri, et al.
Published: (2020-01-01)

KRAS, p53 and BRAF Gene Mutations and Aneuploidy in Sporadic Colorectal Cancer Progression
by: Daniele Calistri, et al.
Published: (2006-01-01)

IDH mutation, glioma immunogenicity, and therapeutic challenge of primary mismatch repair deficient IDH‐mutant astrocytoma PMMRDIA: a systematic review
by: Olfat Ahmad, et al.
Published: (2024-12-01)

Association of G12D mutation in the KRAS gene with HPV and EBV in gastrointestinal cancer tissues
by: Vahideh Hamidi Sofiani, et al.
Published: (2024-12-01)

KRAS and BRAF Mutation Detection: Is Immunohistochemistry a Possible Alternative to Molecular Biology in Colorectal Cancer?
by: Nicolas Piton, et al.
Published: (2015-01-01)

The impact of KRAS mutations on the tumour microenvironment and treatment response in non-small cell lung cancer
by: Guomin Gu, et al.
Published: (2024-12-01)

Brief Report: Not Created Equal: Survival Differences by KRAS Mutation Subtype in NSCLC Treated With Immunotherapy
by: Lova Sun, MD, MSCE, et al.
Published: (2025-01-01)

Probable autoimmune lymphoproliferative syndrome with monogenic lupus due to KRAS mutation - A rare encounter
by: Amiya Nayak, et al.
Published: (2024-02-01)

The Role of KRAS Mutational Analysis to Determine the Site of Origin of Metastatic Carcinoma to the Lung: A Case Report
by: Ahmed N. Alkhasawneh, et al.
Published: (2012-01-01)

KEAP1 mutations as key crucial prognostic biomarkers for resistance to KRAS-G12C inhibitors
by: Linyan Tian, et al.
Published: (2025-01-01)

KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET‐expressing tumor cells
by: Dominic Leiser, et al.
Published: (2015-08-01)

KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent
by: Ullas Batra, et al.
Published: (2023-02-01)

The topography of nullomer-emerging mutations and their relevance to human disease
by: Candace S.Y. Chan, et al.
Published: (2025-01-01)

Unravelling mutational signatures with plasma circulating tumour DNA
by: Sebastian Hollizeck, et al.
Published: (2024-11-01)

Multiomic quantification of the KRAS mutation dosage improves the preoperative prediction of survival and recurrence in patients with pancreatic ductal adenocarcinoma
by: Won-Gun Yun, et al.
Published: (2025-01-01)

Erratum to “The Role of KRAS Mutational Analysis to Determine the Site of Origin of Metastatic Carcinoma to the Lung: A Case Report”
by: Ahmad Alkhasawneh, et al.
Published: (2013-01-01)

The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
by: Wenli Xie, et al.
Published: (2019-03-01)

Clinicopathological relevance of BRAF and SMO mutations in Chinese patients with ameloblastoma
by: Chen Ruixue, et al.
Published: (2023-12-01)

Mutational signature analyses in multi-child families reveal sources of age-related increases in human germline mutations
by: Habiballah Shojaeisaadi, et al.
Published: (2024-11-01)

Mutational signature analysis predicts bacterial hypermutation and multidrug resistance
by: Kalen M. Hall, et al.
Published: (2025-01-01)

Analysis of KRAS Mutations of Exon 2 Codons 12 and 13 by SNaPshot Analysis in Comparison to Common DNA Sequencing
by: Rica Zinsky, et al.
Published: (2010-01-01)

A Disentangled Representation-Based Multimodal Fusion Framework Integrating Pathomics and Radiomics for KRAS Mutation Detection in Colorectal Cancer
by: Zhilong Lv, et al.
Published: (2024-09-01)

Technical evaluation of a novel digital PCR platform for detecting EGFR/KRAS mutations in NSCLC archived plasma specimens
by: Claudia Scimone, et al.
Published: (2024-03-01)

KRAS G12C mutation in NSCLC in a small genetic center: insights into sotorasib therapy response potential
by: Metin Eser, et al.
Published: (2024-11-01)

Study of a panel of genetic mutations in fibrocalcific pancreatic diabetes (FCPD): SPINK1 (N34S) mutation unlikely to be relevant
by: Vijay Budhwar, et al.
Published: (2024-12-01)

Genetic mutations and immune microenvironment: unveiling the connection to AML prognosis
by: ZhongLi Hu, et al.
Published: (2024-12-01)

Mutational Prognosis of Survival by Liquid Biopsy in Advanced EGFRm NSCLC
by: M. Galvez-Nino, et al.
Published: (2023-11-01)

Intercellular TIMP-1-CD63 signaling directs the evolution of immune escape and metastasis in KRAS-mutated pancreatic cancer cells
by: Chu-An Wang, et al.
Published: (2025-01-01)

A Case of Non-Small Cell Lung Cancer with Mutually Exclusive <i>EGFR</i> and <i>KRAS</i> Mutations
by: Abhimanyu Tushir, et al.
Published: (2025-01-01)

Cell-Free (cfDNA) Based Evaluation of KRAS Mutation Profile in Solid Tumors With Focus on G12C Variant
by: S. Limaye, et al.
Published: (2023-11-01)